Covexin 10 Suspension for injection for sheep and cattle

Regulatory record

Marketing authorisation holder

Zoetis Belgium S.A.

Authorisation number

VPA10387/008/001

Authorisation status

AU

Product type

VM

Pharmaceutical form

Suspension for injection

Route of administration

Subcutaneous use

Strength as published

Not stated in source

ATCvet code

QI02AB01; QI04AB01

Market

IE

Active ingredients

• C. tetani toxoid (strain cn 3911)
• C. perfringens type b toxoid (strain cn 1240)
• C. septicum toxoid (strain cn 368)
• C. perfringens type c toxoid (strain cn 883)
• C. novyi type b toxoid (strain cn 6120)
• C. perfringens type d toxoid (strain cn 3688)
• C. haemolyticum toxoid (strain cn 3629)
• C. chauvoei whole culture (strain cn 3796)
• C. sordellii toxoid (strain 831)
• C. perfringens type a toxoid (strain cn 1491)

Target species

Clinical detail

Dosing, withdrawal periods, contraindications and warnings are not published in this pilot. They live in the product's summary of product characteristics and will only appear here once extracted and checked against the source document.

• aboutextraction pending
• formulations and strengthsextraction pending
• indications and contraindicationsextraction pending
• interactionsextraction pending
• administration and dosageextraction pending
• pharmacologyextraction pending
• suppliersextraction pending
• sourcessource linked